<code id='698B430921'></code><style id='698B430921'></style>
    • <acronym id='698B430921'></acronym>
      <center id='698B430921'><center id='698B430921'><tfoot id='698B430921'></tfoot></center><abbr id='698B430921'><dir id='698B430921'><tfoot id='698B430921'></tfoot><noframes id='698B430921'>

    • <optgroup id='698B430921'><strike id='698B430921'><sup id='698B430921'></sup></strike><code id='698B430921'></code></optgroup>
        1. <b id='698B430921'><label id='698B430921'><select id='698B430921'><dt id='698B430921'><span id='698B430921'></span></dt></select></label></b><u id='698B430921'></u>
          <i id='698B430921'><strike id='698B430921'><tt id='698B430921'><pre id='698B430921'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:69766
          The Novartis booth at ESMO in Madrid.
          The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

          MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

          The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

          advertisement

          The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Covid misinformation case heads to Supreme Court
          Covid misinformation case heads to Supreme Court

          AnnaMoneymaker/GettyImagesWASHINGTON—TheSupremeCourtwillthisMarchhearargumentscenteredonthegovernmen

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          New case study details death in closely watched Alzhiemer's trial

          AbrainaffectedbyAlzheimer'sdisease,attheMuseumofNeuroanatomyattheUniversityatBuffalo.DavidDuprey/API